Article Text

Download PDFPDF

Correction: Incidence rates of immune-related adverse events and their correlation with response in advanced solid tumours treated with NIVO or NIVO+IPI: a systematic review and meta-analysis

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Xing P, Zhang F, Wang G, et al. Incidence rates of immune-related adverse events and their correlation with response in advanced solid tumours treated with NIVO or NIVO+IPI: a systematic review and meta-analysis. J ImmunoTher Cancer 2019;7:341. doi: 10.1186/s40425-019-0779-6

In the article titled ‘Incidence rates of immune-related adverse events and their correlation with response in advanced solid tumours treated with NIVO or NIVO+IPI: a systematic review and meta-analysis’, the author noticed that the second corresponding author was not designated in the article.

The correct corresponding authors are:

Junling Li - Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China, 17 Pan-jia-yuan South Lane, Chaoyang District, 100021, Beijing, China. Email: lijunling@cicams.ac.cn

Yan Wang - Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China, 17 Pan-jia-yuan South Lane, Chaoyang District, 100021, Beijing, China. Email: wangyanyifu@126.com